Get started
Author

F. Di Fiore

Strategy for the practice of digestive and oncological surgery during the Covid-19 epidemic
2020 · J.-J. Tuech, A. Gangloff, et al. · Journal of Visceral Surgery · 136
PDF
Safety and outcome of definitive chemoradiotherapy in elderly patients with oesophageal cancer
2008 · D Tougeron, F Di Fiore, et al. · British Journal of Cancer · 124
PDF
Small bowel adenocarcinoma phenotyping, a clinicobiological prognostic study
2013 · T Aparicio, M Svrcek, et al. · British Journal of Cancer · 123
PDF
Randomized phase III trial in elderly patients comparing LV5FU2 with or without irinotecan for first-line treatment of metastatic colorectal cancer (FFCD 2001–02)
2015 · T. Aparicio, S. Lavau-Denes, et al. · Annals of Oncology · 109
PDF
TP53 mutations predict disease control in metastatic colorectal cancer treated with cetuximab-based chemotherapy
2009 · A Oden-Gangloff, F Di Fiore, et al. · British Journal of Cancer · 84
PDF
Prior chemoradiotherapy is associated with a higher life‐threatening complication rate after palliative insertion of metal stents in patients with oesophageal cancer
2006 · S. LECLEIRE, F. DI FIORE, et al. · Alimentary Pharmacology & Therapeutics · 79
Severe clinical toxicities are correlated with survival in patients with advanced renal cell carcinoma treated with sunitinib and sorafenib
2011 · F Di Fiore, O Rigal, et al. · British Journal of Cancer · 53
PDF
Induction cisplatin–irinotecan followed by concurrent cisplatin–irinotecan and radiotherapy without surgery in oesophageal cancer: multicenter phase II FFCD trial
2006 · P Michel, A Adenis, et al. · British Journal of Cancer · 50
PDF
Overweight is associated to a better prognosis in metastatic colorectal cancer: A pooled analysis of FFCD trials
2018 · Thomas Aparicio, Michel Ducreux, et al. · European Journal of Cancer · 46
PDF
Port catheter versus peripherally inserted central catheter for postoperative chemotherapy in early breast cancer: a retrospective analysis of 448 patients
2015 · L. Lefebvre, E. Noyon, et al. · Supportive Care in Cancer · 36
Basal/squamous and mixed subtype bladder cancers present poor outcomes after neoadjuvant chemotherapy in the VESPER trial
2024 · C.S. Groeneveld, C. Pfister, et al. · Annals of Oncology · 33
Lugol chromo-endoscopy versus Narrow Band Imaging for endoscopic screening of esophageal squamous-cell carcinoma in patients with a history of cured esophageal cancer: a feasibility study
2011 · S. Lecleire, M. Antonietti, et al. · Diseases of the Esophagus · 32
FOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases: Results of the FFCD 1102 phase II trial
2018 · J.B. Bachet, O. Lucidarme, et al. · European Journal of Cancer · 29
Chemoradiation with FOLFOX plus cetuximab in locally advanced cardia or esophageal cancer: Final results of a GERCOR phase II trial (ERaFOX).
2011 · L. Dahan, B. Chibaudel, et al. · Journal of Clinical Oncology · 19
Unusual skeletal muscle metastasis from gastric adenocarcinoma
2009 · D. Tougeron, H. Hamidou, et al. · Gastroentérologie Clinique et Biologique · 19
Double stenting of oesophagus and airways in palliative treatment of patients with oesophageal cancer is efficient but associated with a high morbidity
2007 · S. LECLEIRE, M. ANTONIETTI, et al. · Alimentary Pharmacology & Therapeutics · 19
Definitive chemoradiotherapy in patients with esophageal adenocarcinoma: An alternative to surgery?
2011 · D. Tougeron, M. Scotté, et al. · Journal of Surgical Oncology · 17
Design of a randomized controlled phase III study of dose dense methotrexate, vinblastine, doxorubicin and cisplatin (dd-MVAC) or gemcitabine and cisplatin (GC) as peri-operative chemotherapy for patients with locally advanced transitional cell cancer of the bladder. The French GETUG/AFU V05 VESPER trial
2020 · Christian Pfister, Valentin Harter, et al. · Contemporary Clinical Trials Communications · 15
PDF
Control of pelvic symptoms in patients with rectal cancer and synchronous metastases
2009 · D. Tougeron, F. Di Fiore, et al. · Gastroentérologie Clinique et Biologique · 8
Magnetic resonance cholangiographic assessment of a delayed radiation-induced bile duct stricture
2001 · F. Di Fiore, C. Savoye-Collet, et al. · Digestive and Liver Disease · 7
1163P Lanreotide as maintenance therapy after first-line treatment in patients with non-resectable duodeno-pancreatic neuroendocrine tumours (NETs): An international double-blind, placebo-controlled randomized phase II trial
2020 · C. Lepage, J.M. Phelip, et al. · Annals of Oncology · 6
PDF
Circulating ESR1 mutations at the end of aromatase inhibitor adjuvant treatment and after relapse in breast cancer patients
2017 · V. Allouchery, L. Beaussire, et al. · Annals of Oncology · 3
PDF
Valeur pronostique de la toxicité induite par les thérapies ciblées dans le carcinome rénal métastatique
2014 · F.-X. Nouhaud, J.-D. Rebibo, et al. · The French Journal of Urology · 3
650P Genomic profiling of small bowel adenocarcinoma: A pooled analysis
2023 · T. Aparicio, J. Henriques, et al. · Annals of Oncology · 2
PDF
Randomized phase II trial evaluating the safety of peripherally inserted central catheters vs implanted port catheters during adjuvant chemotherapy in early breast cancer patients
2019 · F. Clatot, M. Fontanilles, et al. · Annals of Oncology · 2
PDF
Works count: 68
Citation count: 1,065
H-index: 17
I10-index: 18
Year
Topic
Type